Calpol Tablets

Calpol Tablets are a paracetamol formulation that contains Optizorb technology. Calpol Tablets with Optizorb releases medicine five times faster than standard paracetamol tablets¹.

COVID-19

If you require any further information on COVID-19, go to https://sacoronavirus.co.za/ By clicking on the line above, you will be taken to an external website that is operated and not managed by GSK. GSK assumes no responsibility for the content on the website. If you do not wish to leave this website, do not click on the links above.

Overview

What does it relieve?

Headache
Pain
Toothache

Fever
Pain and fever associated with cold and flu symptoms

What's the format?

Tablets

What are its features?

Releases medicine 5x faster than standard paracetamol¹

What are the ingredients?

500mg Paracetamol

How to use

Swallow tablets with water

Dosage

Age	Tablets	How often
Adults (including the elderly) and children aged 12 years and over	One to two film-coated tablets	Every 4-6 hours as required. Maximum daily dose: 4000mg (8 film-coated tablets)
Children, 6 to 11 years	Half to one film-coated tablet	Every 4-6 hours as required: 6 to 8 years: 250mg (1/2 tablet) 9 - 11 years: 500mg (1 tablet) No more than four doses in any 24-hour period.

Further Information

Maximum duration of continued use without medical advice: 3 days

Enquiries

If you would like any further information regarding Calpol products, please call our INFOLINE (Freecall) South Africa on 0800 118 274

References

^{1. C.G. Wilson, Cyril P. Clarke, Yan Yan L. Starkey & Geoffrey D. Clarke (2011)
Comparison of a novel fast-dissolving acetaminophen tablet formulation (FD-APAP) and standard
acetaminophen tablets using gamma scintigraphy and pharmacokinetic studies, Drug Development
and Industrial Pharmacy, 2011 Jul. 1;37(7):747-53, https://doi.org/10.3109/03639045.2010.538058}

Promotion of Access to Information Act (PAIA)

The PAIA manual is prepared in accordance with section 51 of the Promotion of Access to Information Act (PAIA) No. 2 of 2000 (as amended) and the Protection of Personal Information Act, 2013. The purpose of PAIA is to promote the right of access to information, to foster a culture of transparency and accountability within the Company by giving the right to information that is required for the exercise or protection of any right and to actively promote a society in which the people of South Africa have effective access to information to enable them to exercise and protect their rights.

Please see the PAIA manual

GlaxoSmithKline Consumer Healthcare SA (Pty) Ltd, Company Reg. No 2014/173930/07. 39 Hawkins Avenue, Epping Industria 1, 7460. Tel. No 0800 118 274. For any product related safety issues, please contact +27 11 745 6001 or 0800 118 274.

S0 Calpol film-coated tablets. REG. NO. 44/2.7/0321. Each film-coated tablet contains 500 mg paracetamol. GlaxoSmithKline Consumer Healthcare South Africa (Pty) LTD. 57 Sloane Street, Bryanston 2021. Refer to enclosed leaflet for prescribing information.

Calpol Tablets contains Paracetamol. ALWAYS READ THE LABEL. Use only as directed. For the temporary relief of pain and fever. Incorrect use could be harmful. Consult your healthcare professional if symptoms persist.

The information on this site is intended for visitors from South Africa only.

1. This product contains paracetamol; do not take it with other medicines that also contain paracetamol. Paracetamol is contained in many medicines to treat pain, fever, symptoms of cold and flu, and sleep medicines.
2. If you have liver or kidney disease, talk to your doctor before taking paracetamol.
3. Do not take more than recommended dose, as this may be harmful, including serious harm to your liver.

PM-ZA-CALP-20-00046